Impact of Weekend Admissions on Quality of Care and Outcomes in Patients With Acute Myeloid Leukemia

被引:14
|
作者
Bejanyan, Nelli [1 ]
Fu, Alex Z. [2 ]
Lazaryan, Aleksandr [1 ]
Fu, Rao [3 ]
Kalaycio, Matt [1 ]
Advani, Anjali [1 ]
Sobecks, Ronald [1 ]
Copelan, Edward [1 ]
Maciejewski, Jaroslaw P. [4 ]
Sekeres, Mikkael A. [1 ]
机构
[1] Cleveland Clin, Taussig Canc Inst, Dept Hematol Oncol & Blood Disorders, Cleveland, OH 44195 USA
[2] Cleveland Clin, Taussig Canc Inst, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA
[3] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44195 USA
[4] Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH 44195 USA
基金
美国国家卫生研究院;
关键词
acute myeloid leukemia; hospital admission; weekend admission; length of stay; mortality; triple-lumen catheter; chemotherapy; treatment delay; INDUCTION CHEMOTHERAPY; MYOCARDIAL-INFARCTION; HOSPITAL MORTALITY; OLDER-ADULTS; SURVIVAL; CLASSIFICATION; CRITERIA; CANCER; TRIAL; AML;
D O I
10.1002/cncr.25086
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Hospital services are expectantly reduced over the weekend, which may result in a delay in treatment or in obtainment of medical procedures. The authors investigated quality of care and clinical outcomes of newly diagnosed acute myeloid leukemia (AML) patients who were hospitalized on weekends versus weekdays and treated with induction chemotherapy. METHODS: This retrospective follow-up study involved 422 AML patients treated with cytarabine-based induction chemotherapy at Cleveland Clinic from 1994-2008. Quality outcome measures included time to triple-lumen catheter (TLC) placement, time to induction chemotherapy, length of stay (LOS), early death (within 15 days of chemotherapy), and 30-day mortality. These were tested for the association with known predictors of AML survival and etiology by the methods of linear, categorical, and survival analyses. RESULTS: Twenty-three percent of all admissions (n = 422) occurred over the weekend (n = 103). Compared with younger (aged <60 years) patients, older patients had higher 30-day mortality (P = .003), early death (P = .025), and time to induction rates (P = .02), but lower complete remission (P = .001) and overall survival (OS) rates (P < .0001). In univariate analyses, time to TLC was delayed for weekend admissions (P < .01). Weekend admissions had lower early mortality (P = .04) and 30-day mortality (P = .02). In multivariate analysis, only time to TLC remained significantly longer for weekend admissions (P < .001). CONCLUSIONS: Weekend admissions significantly delayed placement of TLC without affecting other quality parameters or patient survival. This is likely because of immediate initiation of peripheral chemotherapy with cytarabine even before the placement of TLC for infusion of anthracyclines. Cancer 2010;116;3614-20. (C) 2010 American Cancer Society.
引用
收藏
页码:3614 / 3620
页数:7
相关论文
共 50 条
  • [31] Outcomes of Intensive Treatment of Adult Acute Myeloid Leukemia Patients: A Retrospective Study From a Single Centre
    Kalaiyarasi, Jayachandran Perumal
    Ganesan, Prasanth
    Kannan, Krishnarathinam
    Ganesan, Trivadi S.
    Radhakrishnan, Venkatraman
    Dhanushkodi, Manikandan
    Krupashankar, S.
    Mehra, Nikita
    Sagar, Tenali Gnana
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2019, 35 (02) : 248 - 254
  • [32] Outcomes of Patients With Acute Myeloid Leukemia Treated at a SafetyNet Hospital
    Narra, Kalyani
    Bullock, Jolonda
    Neerukonda, Latha
    Ghabach, Bassam
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S240 - S240
  • [33] Economic burden of elderly patients with acute myeloid leukemia treated in routine clinical care in the United States
    Bell, Jill A.
    Galaznik, Aaron
    Farrelly, Eileen
    Blazer, Marlo
    Murty, Sharanya
    Ogbonnaya, Augustina
    Eaddy, Michael
    Fram, Robert J.
    Faller, Douglas, V
    Kota, Vamsi
    LEUKEMIA RESEARCH, 2018, 71 : 27 - 33
  • [34] Health Care Utilization and End-of-Life Care for Older Patients With Acute Myeloid Leukemia
    El-Jawahri, Areej R.
    Abel, Gregory A.
    Steensma, David P.
    LeBlanc, Thomas W.
    Fathi, Amir T.
    Graubert, Timothy A.
    DeAngelo, Daniel J.
    Wadleigh, Martha
    Ballen, Karen K.
    Foster, Julia E.
    Attar, Eyal C.
    Amrein, Philip C.
    Brunner, Andrew M.
    Stone, Richard M.
    Temel, Jennifer S.
    CANCER, 2015, 121 (16) : 2840 - 2848
  • [35] Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemia
    Chisini, Marta
    Stefanizzi, Caterina
    Ceglie, Teresa
    Raponi, Sara
    Vozella, Federico
    Colafigli, Gioia
    Salaroli, Adriano
    D'Angio, Mariella
    Mancini, Marco
    Diverio, Daniela
    Breccia, Massimo
    Mancini, Francesca
    Minotti, Clara
    Trisolini, Silvia
    Capria, Saveria
    Testi, Anna Maria
    Guarini, Anna
    Latagliata, Roberto
    de Propris, Maria Stefania
    Foa, Robin
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) : 804 - 809
  • [36] Cardiovascular Disease and Diabetes Mellitus Impact Outcomes of Patients With Acute Myeloid Leukemia
    Sanchez-Petitto, Gabriela
    Goloubeva, Olga G.
    Masur, Jack
    Childress, James
    Iqbal, Tahreem
    An, Max
    Muhammad, Safwan
    Lawson, Justin
    Barr, Brian
    Emadi, Ashkan
    Law, Jennie
    Duong, Vu H.
    Baer, Maria R.
    Niyongere, Sandrine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S242 - S243
  • [37] Air pollutant impact on disease characteristics and outcomes in patients with acute myeloid leukemia
    Palmer, Andrew
    Rauscher, Garth
    Abraham, Ivy
    Burkart, Madelyn
    Dave, Ami
    Raptis, Nepheli
    Aleem, Ahmed
    Gannamani, Vedavyas
    Erra, Amani
    Monick, Sarah
    Galvez, Carlos
    Shah, Syed
    Youshanlouei, Hamed Rahmani
    Larson, Melissa L.
    Zia, Maryam
    Tsai, Stephanie B.
    Altman, Jessica K.
    Stock, Wendy
    Khan, Irum
    Patel, Anand A.
    BLOOD ADVANCES, 2024, 8 (17) : 4647 - 4650
  • [38] Economic Evaluation of Azacitidine in Elderly Patients with Acute Myeloid Leukemia with High Blast Counts
    Coyle, D.
    Villeneuve, Pierre J. A.
    PHARMACOECONOMICS-OPEN, 2020, 4 (02) : 297 - 305
  • [39] Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia
    Nasir, Syed Sameer
    Giri, Smith
    Nunnery, Sara
    Martin, Mike G.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (02) : 126 - 132
  • [40] Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes
    Ferraro, Francesca
    Miller, Christopher A.
    Christensen, Keegan A.
    Helton, Nichole M.
    O'Laughlin, Margaret
    Fronick, Catrina C.
    Fulton, Robert S.
    Kohlschmidt, Jessica
    Eisfeld, Ann-Kathrin
    Bloomfield, Clara D.
    Ramakrishnan, Sai Mukund
    Day, Ryan B.
    Wartman, Lukas D.
    Uy, Geoffrey L.
    Welch, John S.
    Christopher, Matthew J.
    Heath, Sharon E.
    Baty, Jack D.
    Schuelke, Matthew J.
    Payton, Jacqueline E.
    Spencer, David H.
    Rettig, Michael P.
    Link, Daniel C.
    Walter, Matthew J.
    Westervelt, Peter
    DiPersio, John F.
    Ley, Timothy J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (49)